Report Detail
Global Monoclonal Antibody Service Market Size, Status and Forecast 2019-2025
- RnM3207277 |
- 22 May, 2019 |
- Global |
- 100 Pages |
- QYResearch |
- Other
In 2018, the global Monoclonal Antibody Service market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Monoclonal Antibody Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Monoclonal Antibody Service development in United States, Europe and China.
The key players covered in this study
Pfizer
Roche
Eli Lilly
Bayer
Amgen
Sanofi-Aventis
Johnson & Johnson
Novo Nordisk
Merck
Abbott Laboratories
GSK
BMS
Alexion
UCB
Seattle Genetics
Market segment by Type, the product can be split into
Reagents
Drugs
Other
Market segment by Application, split into
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Monoclonal Antibody Service status, future forecast, growth opportunity, key market and key players.
To present the Monoclonal Antibody Service development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Monoclonal Antibody Service are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Monoclonal Antibody Service Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Reagents
- 1.4.3 Drugs
- 1.4.4 Other
- 1.5 Market by Application
- 1.5.1 Global Monoclonal Antibody Service Market Share by Application (2014-2025)
- 1.5.2 Diagnostic Laboratories
- 1.5.3 Research & Academic Laboratories
- 1.5.4 Pharmaceutical & Biotechnology Companies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Monoclonal Antibody Service Market Size
- 2.2 Monoclonal Antibody Service Growth Trends by Regions
- 2.2.1 Monoclonal Antibody Service Market Size by Regions (2014-2025)
- 2.2.2 Monoclonal Antibody Service Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Monoclonal Antibody Service Market Size by Manufacturers
- 3.1.1 Global Monoclonal Antibody Service Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Monoclonal Antibody Service Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Monoclonal Antibody Service Market Concentration Ratio (CR5 and HHI)
- 3.2 Monoclonal Antibody Service Key Players Head office and Area Served
- 3.3 Key Players Monoclonal Antibody Service Product/Solution/Service
- 3.4 Date of Enter into Monoclonal Antibody Service Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Monoclonal Antibody Service Market Size by Type (2014-2019)
- 4.2 Global Monoclonal Antibody Service Market Size by Application (2014-2019)
5 United States
- 5.1 United States Monoclonal Antibody Service Market Size (2014-2019)
- 5.2 Monoclonal Antibody Service Key Players in United States
- 5.3 United States Monoclonal Antibody Service Market Size by Type
- 5.4 United States Monoclonal Antibody Service Market Size by Application
6 Europe
- 6.1 Europe Monoclonal Antibody Service Market Size (2014-2019)
- 6.2 Monoclonal Antibody Service Key Players in Europe
- 6.3 Europe Monoclonal Antibody Service Market Size by Type
- 6.4 Europe Monoclonal Antibody Service Market Size by Application
7 China
- 7.1 China Monoclonal Antibody Service Market Size (2014-2019)
- 7.2 Monoclonal Antibody Service Key Players in China
- 7.3 China Monoclonal Antibody Service Market Size by Type
- 7.4 China Monoclonal Antibody Service Market Size by Application
8 Japan
- 8.1 Japan Monoclonal Antibody Service Market Size (2014-2019)
- 8.2 Monoclonal Antibody Service Key Players in Japan
- 8.3 Japan Monoclonal Antibody Service Market Size by Type
- 8.4 Japan Monoclonal Antibody Service Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Monoclonal Antibody Service Market Size (2014-2019)
- 9.2 Monoclonal Antibody Service Key Players in Southeast Asia
- 9.3 Southeast Asia Monoclonal Antibody Service Market Size by Type
- 9.4 Southeast Asia Monoclonal Antibody Service Market Size by Application
10 India
- 10.1 India Monoclonal Antibody Service Market Size (2014-2019)
- 10.2 Monoclonal Antibody Service Key Players in India
- 10.3 India Monoclonal Antibody Service Market Size by Type
- 10.4 India Monoclonal Antibody Service Market Size by Application
11 Central & South America
- 11.1 Central & South America Monoclonal Antibody Service Market Size (2014-2019)
- 11.2 Monoclonal Antibody Service Key Players in Central & South America
- 11.3 Central & South America Monoclonal Antibody Service Market Size by Type
- 11.4 Central & South America Monoclonal Antibody Service Market Size by Application
12 International Players Profiles
- 12.1 Pfizer
- 12.1.1 Pfizer Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Monoclonal Antibody Service Introduction
- 12.1.4 Pfizer Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.1.5 Pfizer Recent Development
- 12.2 Roche
- 12.2.1 Roche Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Monoclonal Antibody Service Introduction
- 12.2.4 Roche Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.2.5 Roche Recent Development
- 12.3 Eli Lilly
- 12.3.1 Eli Lilly Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Monoclonal Antibody Service Introduction
- 12.3.4 Eli Lilly Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.3.5 Eli Lilly Recent Development
- 12.4 Bayer
- 12.4.1 Bayer Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Monoclonal Antibody Service Introduction
- 12.4.4 Bayer Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.4.5 Bayer Recent Development
- 12.5 Amgen
- 12.5.1 Amgen Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Monoclonal Antibody Service Introduction
- 12.5.4 Amgen Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.5.5 Amgen Recent Development
- 12.6 Sanofi-Aventis
- 12.6.1 Sanofi-Aventis Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Monoclonal Antibody Service Introduction
- 12.6.4 Sanofi-Aventis Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.6.5 Sanofi-Aventis Recent Development
- 12.7 Johnson & Johnson
- 12.7.1 Johnson & Johnson Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Monoclonal Antibody Service Introduction
- 12.7.4 Johnson & Johnson Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.7.5 Johnson & Johnson Recent Development
- 12.8 Novo Nordisk
- 12.8.1 Novo Nordisk Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Monoclonal Antibody Service Introduction
- 12.8.4 Novo Nordisk Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.8.5 Novo Nordisk Recent Development
- 12.9 Merck
- 12.9.1 Merck Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Monoclonal Antibody Service Introduction
- 12.9.4 Merck Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.9.5 Merck Recent Development
- 12.10 Abbott Laboratories
- 12.10.1 Abbott Laboratories Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Monoclonal Antibody Service Introduction
- 12.10.4 Abbott Laboratories Revenue in Monoclonal Antibody Service Business (2014-2019)
- 12.10.5 Abbott Laboratories Recent Development
- 12.11 GSK
- 12.12 BMS
- 12.13 Alexion
- 12.14 UCB
- 12.15 Seattle Genetics
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Monoclonal Antibody Service . Industry analysis & Market Report on Monoclonal Antibody Service is a syndicated market report, published as Global Monoclonal Antibody Service Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Monoclonal Antibody Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
